Stanford Investment Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,790
| Closed | -$122K | – | 18 |
|
|
2016
Q4 | $122K | Hold |
11,790
| – | – | 0.06% | 76 |
|
|
2016
Q3 | $146K | Hold |
11,790
| – | – | 0.07% | 69 |
|
|
2016
Q2 | $127K | Hold |
11,790
| – | – | 0.06% | 79 |
|
|
2016
Q1 | $130K | Hold |
11,790
| – | – | 0.07% | 77 |
|
|
2015
Q4 | $144K | Hold |
11,790
| – | – | 0.08% | 73 |
|
|
2015
Q3 | $192K | Hold |
11,790
| – | – | 0.14% | 49 |
|
|
2015
Q2 | $250K | Hold |
11,790
| – | – | 0.19% | 41 |
|
|
2015
Q1 | $212K | Hold |
11,790
| – | – | 0.17% | 45 |
|
|
2014
Q4 | $202K | Buy |
+11,790
| New | +$202K | 0.17% | 48 |
|